Sign In

John Steuart

Executive Chairman at County Sports Zone

Professional Background

John Steuart is an active venture and private equity investor known for his extensive experience in nurturing and scaling high-growth projects across various sectors, including life sciences, technology, and real estate. With 25 years of seasoned experience as an entrepreneur, CFO, board member, and venture capitalist, John's career reflects a dynamic ability to innovate and lead in both public and private company settings.

In 1988, John made a significant mark as the co-founder of Savvy Properties, L.P., sharing this journey with Michael Kraszulyak. This marked the beginning of a fruitful co-founding partnership that has characterized many of John's ventures. He took on pivotal roles in several companies, serving as managing director for Claremont Creek Ventures, Prolog Ventures, and Steuart Ventures, amplifying their growth and market presence.

John's illustrious entrepreneurial journey includes the co-founding of CyberGold in 1995, an innovative company in Internet payments and loyalty marketing. Under his leadership, CyberGold expanded dramatically from a modest beginning with three co-founders to a workforce of 150 employees. Following this dynamic growth, the company achieved a successful IPO and engaged in a $500 million merger with its competitor, MyPoints. This strategic maneuver ultimately attracted the interest of United Airlines, leading John to serve as the Senior Vice President of Strategic Partnerships at United Airlines New Ventures, where his insights into corporate investments were crucial for nurturing new business ideas.

In 2007, John's keen foresight led him to spearhead the Series A investment in Natera, a molecular diagnostics company, alongside renowned venture capital firm Sequoia Capital. This investment has proven to be extremely fruitful, culminating in Natera's IPO in July 2015. John's strategic acumen continues to reflect in his successes, such as the impressive $425 million acquisition of his portfolio company GeneWeave by Roche in August 2015, and the acquisition of Assurex by Myriad Genetics in August 2016 for $410 million. Currently, John contributes his insights as a board member for Natera (NASDAQ: NTRA), SmartZip, and Rally4, enriching the strategic direction of these companies.

Beyond his investing ventures, John is also committed to nurturing the next generation of innovators. He serves as an Industry Fellow at the Center for Entrepreneurship and Technology at the College of Engineering and is an esteemed member of the Advisory Council for the Lester Center's Berkeley Entrepreneurs' Forum at UC Berkeley, where his wealth of knowledge in entrepreneurship and venture capital is invaluable to budding entrepreneurs.

Education and Achievements

John Steuart holds strong academic qualifications that have been instrumental in shaping his career in venture capital and biomedical investment. He completed his Ph.D. in Immunology/Microbiology at the Indiana University School of Medicine, furthering his expertise as a postdoctoral fellow in Immunology at the prestigious Washington University School of Medicine.

His early career experiences have been pivotal in establishing him as a noteworthy figure in the biotech and venture capital landscape. John began his journey at Alafi Capital, a venture capital firm dedicated to early-stage biomedical companies. He played a crucial role here as an officer of the General Partner, where he led investments in over a dozen successful startups and held key executive and board member positions in various firms. Notable achievements from this period include investments leading to acquisitions by leading corporations, such as Tanox (acquired by Genentech), Software Ventures (acquired by PSInet), Lipomatrix (acquired by Collagen Corp.), and Megan Health (acquired by Avant Immunotherapeutics).

John's ongoing contributions to various boards and organizations, including his roles as Director at Moleculera Labs, and his former leadership positions at Prolog Ventures and The Yield Lab, highlight his commitment to fostering innovation and growth within the venture capital ecosystem.

Achievements

John Steuart's career has been dotted with significant achievements that underscore his expertise and influence in the areas of venture capital and biotechnology. Some of his noteworthy accomplishments include:

  • CyberGold: Co-founding the Internet payments and loyalty marketing company which achieved a successful IPO and a subsequent merger worth $500 million.
  • Natera: Leading the Series A funding round, which facilitated the company's IPO, enhancing its market position in the molecular diagnostic landscape.
  • GeneWeave Acquisition: Orchestrating the acquisition of his portfolio company GeneWeave by Roche for $425 million, showcasing his ability to identify and nurture future market leaders.
  • Assurex Acquisition: Spearheading the successful sale of Assurex for $410 million to Myriad Genetics.
  • Board Leadership: Ongoing contributions to the strategic direction and governance of companies like Natera (NTRA), SmartZip, and Rally4 demonstrate his commitment to driving innovation and growth.
  • Academic Contributions: Serving as an Industry Fellow and Advisory Council member, mentoring emerging entrepreneurs and delving into the future of technology and entrepreneurship.

Through his dynamic career, John Steuart has consistently exemplified what it means to be a leader in venture capital and a supporter of innovative enterprises. His unique blend of entrepreneurship, strategic investment, and leadership in the biotechnology field positions him as a highly respected figure in his industry, inspiring others to follow in his footsteps.

tags':['venture capital','private equity','entrepreneurship','biotechnology','life sciences','strategic partnerships','startups','public companies','board leadership','clinical research','internet payments','IPO success','molecular diagnostics'],

questions

John Steuart
Add to my network

Location

San Francisco Bay Area